Cargando…
Transcriptomic analysis of pancreatic cancer cells in response to metformin and aspirin: an implication of synergy
Metformin and aspirin have been studied extensively as cancer preventative and therapeutic agents. However, the underlying molecular mechanisms for the inhibitory effects of pancreatic cancer development remain undefined. To gain further insight into their biological function in pancreatic cancer, w...
Autores principales: | Yue, Wen, Wang, Tao, Zachariah, Emmanuel, Lin, Yong, Yang, Chung S., Xu, Qing, DiPaola, Robert S., Tan, Xiang-Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4543968/ https://www.ncbi.nlm.nih.gov/pubmed/26294325 http://dx.doi.org/10.1038/srep13390 |
Ejemplares similares
-
Metformin combined with aspirin significantly inhibit pancreatic cancer cell growth in vitro and in vivo by suppressing anti-apoptotic proteins Mcl-1 and Bcl-2
por: Yue, Wen, et al.
Publicado: (2015) -
Inference of synergy/antagonism between anticancer drugs from the pooled analysis of clinical trials
por: Kang, Wenfeng, et al.
Publicado: (2013) -
Axl receptor tyrosine kinase is up-regulated in metformin resistant prostate cancer cells
por: Bansal, Nitu, et al.
Publicado: (2015) -
Comparison of the Neuroprotective Effects of Aspirin, Atorvastatin, Captopril and Metformin in Diabetes Mellitus
por: Paseban, Maryam, et al.
Publicado: (2019) -
Associations of aspirin, statins and metformin with lung cancer risk and related mortality
por: Frille, Armin, et al.
Publicado: (2021)